Media stories about Nanosphere (NASDAQ:NSPH) have trended somewhat positive on Saturday, Accern Sentiment reports. Accern ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Nanosphere earned a coverage optimism score of 0.14 on Accern’s scale. Accern also gave news articles about the medical research company an impact score of 46.0087538335989 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Nanosphere (NASDAQ:NSPH) traded down $0.01 during mid-day trading on Friday, hitting $1.69. 186,100 shares of the company were exchanged, compared to its average volume of 886,293. Nanosphere has a 1-year low of $0.48 and a 1-year high of $3.64.
TRADEMARK VIOLATION NOTICE: This article was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.dispatchtribunal.com/2017/11/11/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-nanosphere-nsph-share-price.html.
Nanosphere Company Profile
Nanosphere, Inc is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. The Verigene System includes a molecular diagnostics workstation that is a single use consumable for testing.
Receive News & Ratings for Nanosphere Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanosphere Inc. and related companies with MarketBeat.com's FREE daily email newsletter.